Avrum Spira
Inventor
Stats
- 3 US patents issued
- 33 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 3 US Patents Issued
- 33 US Applications Filed
- 81 Total Citation Count
- Sep 8, 2022 Most Recent Filing
- Nov 12, 2004 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| UNIVERSITY OF UTAH | 1
| 2008
|
| BRITISH COLUMBIA CANCER AGENCY BRANCH | 2
1 | 2013
2017 |
| THE UNIVERSITY OF BRITISH COLUMBIA | 2
1 | 2012
2017 |
| TRUSTEES OF BOSTON UNIVERSITY | 1
1 1 1 1 2 3 1 4 2 2 4 | 2004
2005 2006 2007 2008 2009 2010 2011 2012 2013 2015 2017 |
| MADRYN HEALTH PARTNERS, LP | 1
3 | 2005
2015 |
Inventor Addresses
| Address | Duration |
|---|---|
| Boston, MA, US | Feb 11, 10 - Feb 11, 10 |
| NEWTON, MA, US | Aug 04, 11 - Feb 16, 12 |
| Newton, MA | Jul 13, 06 - Jun 28, 07 |
| Newton, MA, US | Mar 05, 09 - May 07, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61B: | DIAGNOSIS; SURGERY; IDENTIFICATION | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 7 |
| A61M: | DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 11977076 | 2024 | Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells | 0 |
| 2023/0235,401 | 2023 | BIOMARKERS FOR SMOKE EXPOSURE | 1 |
| 2021/0381,062 | 2021 | NASAL EPITHELIUM GENE EXPRESSION SIGNATURE AND CLASSIFIER FOR THE PREDICTION OF LUNG CANCER | 1 |
| 2021/0254,171 | 2021 | GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS | 0 |
| 10927417 | 2021 | Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions | 3 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.